|
"lin chia chi"的相關文件
顯示項目 41-65 / 148 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:18:47Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
林家齊;楊志新;廖斌志;陳雅芳;余忠仁;何肇基;施金元;李日翔;張晉豪; Liao, Bin-Chi;Lee, Jih-Hsiang;Lin, Chia-Chi;Chen, Ya-Fang;Chang, Chin-Hao;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin; Chong-Jen Yu; Liao, Bin-Chi; Liao, Bin-Chi; YA-FANG CHEN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; CHAO-CHI HO; Lin, Chia-Chi; Lin, Chia-Chi; Chen, Ya-Fang; JIN-YUAN SHIH; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu, Chih-Hung; Cheng, Ann-Lii; Yeh, Kun-Huei; Wang, Hsiu-Po; Cheng, Jason Chia-Hsien; Lee, Jang-Ming; Huang, Pei-Ming; Chang, Chin-Hao; Hsieh, Min-Shu; PEI-MING HUANG; Lin, Chia-Chi; ANN-LII CHENG; JANG-MING LEE; Guo, Jhe-Cyuan;Huang, Ta-Chen;Lin, Chia-Chi;Hsieh, Min-Shu;Chang, Chin-Hao;Huang, Pei-Ming;Lee, Jang-Ming;Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Wang, Hsiu-Po;Yeh, Kun-Huei;Cheng, Ann-Lii;Hsu, Chih-Hung; Guo, J.-C. and Huang, T.-C. and Lin, C.-C. and Hsieh, M.-S. and Chang, C.-H. and Huang, P.-M. and Lee, J.-M. and Hsu, F.-M. and Cheng, J.C.-H. and Wang, H.-P. and Yeh, K.-H. and Cheng, A.-L. and Hsu, C.-H.; 林家齊;鄭安理;成佳憲;黃大成;徐志宏;葉坤輝;謝明書;郭哲銓;李章銘;王秀伯;黃培銘;許峰銘;張晉豪; MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; Hsu, Feng-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; Wang, Chia-Chun;Cheng, Jason Chia-Hsien;Tsai, Chiao-Ling;Lee, Jang-Ming;Huang, Pei-Ming;Lin, Chia-Chi;Hsu, Chih-Hung;Hsieh, Min-Shu;Chang, Yih-Leong;Hsu, Feng-Ming; Wang, C.-C. and Cheng, J.C.-H. and Tsai, C.-L. and Lee, J.-M. and Huang, P.-M. and Lin, C.-C. and Hsu, C.-H. and Hsieh, M.-S. and Chang, Y.-L. and Hsu, F.-M.; 林家齊;張逸良;成佳憲;王嘉檇;徐志宏;謝明書;李章銘;黃培銘;蔡巧琳;許峰銘; 成佳憲; Wang, Chia-Chun; YIH-LEONG CHANG; JANG-MING LEE; Cheng, Jason Chia-Hsien; PEI-MING HUANG; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Treating patients with ALK -positive non-small cell lung cancer: Latest evidence and management strategy
|
Liao, B.-C. and Lin, C.-C. and Shih, J.-Y. and Yang, J.C.-H.; Liao, Bin-Chi;Lin, Chia-Chi;Shih, Jin-Yuan;Yang, James Chih-Hsin; 林家齊;楊志新;廖斌志;施金元; 林家齊;楊志新;廖斌志;施金元; Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T09:51:47Z |
Case report
|
Lin, Chia-Chi;Wang, Jann-Yuan;Pu, Yeong-Shiau; Lin, C.-C. and Wang, J.-Y. and Pu, Y.-S.; 林家齊 ;蒲永孝 ;王振源; Lin, Chia-Chi; JANN-YUAN WANG; Wang, Jann-Yuan; YEONG-SHIAU PU; Pu, Yeong-Shiau |
| 臺大學術典藏 |
2018-09-10T06:13:47Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin, Chia-Chi;Chih-Hung;Hsu;Huang, Chao-Yuan;Keng, Hsiao-Yi;Tsai, Yu-Chieh;Huang, Kuo-How;Cheng, Ann-Lii;Pu, Yeong-Shiau; Lin, C.-C. and Hsu, C.-H. and Huang, C.-Y. and Keng, H.-Y. and Tsai, Y.-C. and Huang, K.-H. and Cheng, A.-L. and Pu, Y.-S.; Lin, Chia-Chi; CHAO-YUAN HUANG; CHIH-HUNG HSU; Chih-Hung; Hsu; KUO-HOW HUANG; YU-CHIEH TSAI; Huang, Chao-Yuan; ANN-LII CHENG; Keng, Hsiao-Yi; Tsai, Yu-Chieh; YEONG-SHIAU PU; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立交通大學 |
2018-01-24T07:39:31Z |
知覺風險、資訊不足性、產品類型與資訊搜尋意圖之關聯探討－以基因改造食品為例
|
林嘉琪; 丁承; Lin, Chia-Chi; Ding, Cherng |
| 國立交通大學 |
2017-04-21T06:49:41Z |
Bit-Error-Rate and Chirp analyses of a Gain-Switching VCSEL based All-Optical NRZ-to-RZ Converter
|
Chi, Yu-Chieh; Lin, Chia-Chi; Kuo, Hao-Chung; Peng, Peng-Chun; Lin, Gong-Ru |
| 國立臺北護理健康大學 |
2016 |
臺灣老人的壓力源、休閒活動與生活滿意度和憂鬱情緒之相關性－緩衝作用之探討
|
林家祺; Lin, Chia-Chi |
| 國立臺灣大學 |
2016 |
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
|
Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯 |
| 國立臺灣大學 |
2016 |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao, Bin-Chi; Lin, Chia-Chi; Lee, Jih-Hsiang; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 李日翔 |
| 國立臺灣大學 |
2016 |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Profile of the therascreen (R) EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer
|
Chen, Kai-Lung; Lin, Chia-Chi; Cho, Yung-Tsu; Yang, Che-Wen; Sheen, Yi-Shuan; Tsai, Hsiao-En; Chu, Chia-Yu; 林家齊; 朱家瑜; 沈宜萱 |
| 國立臺灣大學 |
2016 |
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
|
Minami, Hironobu; Ando, Yuichi; Ma, Brigette Buig Yue; Lee, Jih-Hsiang; Momota, Hiroyuki; Fujiwara, Yutaka; Li, Leung; Fukino, Koichi; Ito, Koji; Tajima, Takeshi; Mori, Asuka; Lin, Chia-Chi; 林家齊; 李日翔 |
| 國立臺灣大學 |
2015 |
探討度冬大杓鷸族群在彰化灘地之分布
|
林家琪; Lin, Chia-Chi |
| 國立臺灣大學 |
2015 |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang, Chia-Chun; Cheng, Jason Chia-Hsien; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung; Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; 林家齊; 張逸良; 成佳憲; 王嘉檇; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC)
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 王秀伯; 張晉豪 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯; 黃培銘; 許峰銘; 張晉豪 |
| 國立臺灣大學 |
2015 |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊 |
| 國立臺灣大學 |
2015 |
A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
|
Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新 |
| 國立臺灣大學 |
2015 |
Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.
|
Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 余忠仁; 何肇基; 施金元; 李日翔 |
| 國立臺灣大學 |
2015 |
Ipilimumab in treating Asian patient with advanced melanoma: The preliminary report of Taiwan ipilimumab extended access program group
|
Wu, Chun-Feng; Huang, Wen Kuan; Liu, Jun-Huang; Lin, Chen-Yuan; Liu, Ta-Chih; Lin, Chia-Chi; Su, Wu-Chou; Yeh, Yumin; Cheng, Shih-Tsung; Lin, Sheng-Fung; Hong, Ruey-Long; Chang, John W. C.; 林家齊; 洪瑞隆 |
| 國立臺灣大學 |
2015 |
Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer
|
Liao, Bin-Chi; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志 |
| 國立臺灣大學 |
2015 |
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy
|
Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 施金元 |
顯示項目 41-65 / 148 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
